Peru's Digemid orders nationwide recall of QM Pharma Pantoprazol 40 mg

Peru's drug regulatory authority, Digemid, has mandated the recall and destruction of all Pantoprazol 40 mg batches produced by QM Pharma. The action follows identified failures in active ingredient dissolution, which renders the medication ineffective for treating gastroesophageal reflux and ulcers.